B-Cell Subset Analysis Predicts SARS-CoV-2 Vaccine Response in Solid Organ Transplant Recipients

Overview

This study identifies distinct B-cell compartment profiles in solid organ transplant recipients (SOTRs) that correlate with their serologic responses to SARS-CoV-2 vaccination. Three B-cell–based groups were characterized, revealing a hierarchy of immune impairment and providing novel predictors of vaccine responsiveness in this immunocompromised population.

Background

Solid organ transplant recipients require chronic immunosuppressive therapy to prevent graft rejection, which increases their susceptibility to infections and complicates immune competence assessment. Traditional evaluation methods, such as measuring vaccine-induced antibody titers, are limited by delayed responses and confounding immune memory. The SARS-CoV-2 pandemic offered a unique opportunity to study immune responses to a novel antigen, focusing on B-cell phenotypes as potential biomarkers of immune competence in SOTRs.

Data Highlights

Key Findings

• K-means clustering identified three distinct B-cell compartment groups among SOTRs correlating with SARS-CoV-2 vaccine antibody responses.
• Group 1 SOTRs exhibited a naive B-cell dominant profile and robust serologic responses similar to healthcare worker controls.
• Group 2 showed reduced naive but expanded memory B cells with variable vaccine responses dependent on immunosuppressive therapy.
• Group 3 had generalized B-cell lymphopenia and poor antibody responses to vaccination.
• Antibody repertoire analysis revealed reduced clonal diversity in SOTRs regardless of memory B-cell numbers, indicating impaired B-cell maturation.
• Even SOTRs with strong immune responses demonstrated diminished vaccine-specific B-cell maturation and diversity compared to healthy controls.

Clinical Implications

B-cell subset profiling offers a rapid and informative method to assess immune competence in SOTRs, potentially guiding personalized vaccination strategies and immunosuppressive management. Identifying patients with impaired B-cell compartments may help clinicians anticipate poor vaccine responses and consider additional protective interventions.

Conclusion

This integrated analysis reveals a hierarchy of B-cell impairment in solid organ transplant recipients that correlates with SARS-CoV-2 vaccine responsiveness, providing a novel framework for immune monitoring and risk stratification in immunocompromised patients.

References

1. Author/Source/Year -- B-Cell Subset Analysis as a Predictor of Vaccine Response to SARS-CoV-2 in Recipients of Solid Organ Transplants